[go: up one dir, main page]

PL3618821T3 - Postępowanie w przypadku nerkopochodnej moczówki prostej - Google Patents

Postępowanie w przypadku nerkopochodnej moczówki prostej

Info

Publication number
PL3618821T3
PL3618821T3 PL18748236.9T PL18748236T PL3618821T3 PL 3618821 T3 PL3618821 T3 PL 3618821T3 PL 18748236 T PL18748236 T PL 18748236T PL 3618821 T3 PL3618821 T3 PL 3618821T3
Authority
PL
Poland
Prior art keywords
managing
diabetes insipidus
nephrogenic diabetes
nephrogenic
insipidus
Prior art date
Application number
PL18748236.9T
Other languages
English (en)
Inventor
Jeff SANDS
Janet KLEIN
Ish Khanna
Sivaram Pillarisetti
Original Assignee
Nephrodi Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nephrodi Therapeutics, Inc. filed Critical Nephrodi Therapeutics, Inc.
Publication of PL3618821T3 publication Critical patent/PL3618821T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL18748236.9T 2017-01-31 2018-01-31 Postępowanie w przypadku nerkopochodnej moczówki prostej PL3618821T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762452616P 2017-01-31 2017-01-31
PCT/US2018/016184 WO2018144570A1 (en) 2017-01-31 2018-01-31 Managing nephrogenic diabetes insipidus

Publications (1)

Publication Number Publication Date
PL3618821T3 true PL3618821T3 (pl) 2025-07-07

Family

ID=63040033

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18748236.9T PL3618821T3 (pl) 2017-01-31 2018-01-31 Postępowanie w przypadku nerkopochodnej moczówki prostej

Country Status (14)

Country Link
US (3) US11179354B2 (pl)
EP (1) EP3618821B8 (pl)
AU (1) AU2018217038B2 (pl)
CA (1) CA3071385A1 (pl)
DK (1) DK3618821T3 (pl)
ES (1) ES3024479T3 (pl)
FI (1) FI3618821T3 (pl)
HR (1) HRP20250377T1 (pl)
HU (1) HUE071486T2 (pl)
LT (1) LT3618821T (pl)
PL (1) PL3618821T3 (pl)
PT (1) PT3618821T (pl)
SI (1) SI3618821T1 (pl)
WO (1) WO2018144570A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9827222B2 (en) 2013-07-01 2017-11-28 Emory University Treating or preventing nephrogenic diabetes insipidus
EP3618821B8 (en) 2017-01-31 2025-04-23 NephroDI Therapeutics, Inc. Managing nephrogenic diabetes insipidus
US20230364039A1 (en) * 2020-10-14 2023-11-16 Emory University Methods of Managing Side Effects of a Vasopressin Receptor Antagonist Therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5864381A (en) 1996-07-10 1999-01-26 Sandia Corporation Automated pupil remapping with binary optics
US7335689B2 (en) 2003-01-23 2008-02-26 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
WO2006060079A2 (en) * 2004-10-25 2006-06-08 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
CN103327974A (zh) 2010-09-20 2013-09-25 卡留斯治疗公司 用于治疗糖尿病和血脂异常的方法和组合物
US20140121267A1 (en) 2011-09-20 2014-05-01 Kareus Therapeutics, Sa Methods and compositions for treatment of diabetes and dyslipidemia
US9827222B2 (en) 2013-07-01 2017-11-28 Emory University Treating or preventing nephrogenic diabetes insipidus
WO2015101609A1 (en) 2013-12-31 2015-07-09 Stichting Katholieke Universiteit Method for treating renal disorders
EP3618821B8 (en) 2017-01-31 2025-04-23 NephroDI Therapeutics, Inc. Managing nephrogenic diabetes insipidus

Also Published As

Publication number Publication date
US20240139127A1 (en) 2024-05-02
HRP20250377T1 (hr) 2025-07-18
PT3618821T (pt) 2025-05-14
US20220031639A1 (en) 2022-02-03
LT3618821T (lt) 2025-05-26
AU2018217038A1 (en) 2020-07-02
ES3024479T3 (en) 2025-06-04
CA3071385A1 (en) 2018-08-09
US11844770B2 (en) 2023-12-19
WO2018144570A1 (en) 2018-08-09
EP3618821B1 (en) 2025-03-12
EP3618821A4 (en) 2021-03-03
SI3618821T1 (sl) 2025-07-31
EP3618821B8 (en) 2025-04-23
EP3618821A1 (en) 2020-03-11
AU2018217038B2 (en) 2023-07-06
US11179354B2 (en) 2021-11-23
US12433858B2 (en) 2025-10-07
DK3618821T3 (da) 2025-04-07
HUE071486T2 (hu) 2025-09-28
US20200383940A1 (en) 2020-12-10
FI3618821T3 (fi) 2025-06-20

Similar Documents

Publication Publication Date Title
KR102179470B9 (ko) 제어가능한 외부 디바이스들을 관리하기 위한 사용자 인터페이스
AU201715824S (en) Phone
EP3089664A4 (en) Adaptive replanning based on multimodality imaging
SG10201710814WA (en) User controlled call management
EP3046600A4 (en) Insulin management
EP3046599A4 (en) Insulin management
EP3132345A4 (en) Application managing application
EP3025283A4 (en) Managing reviews
EP3698526C0 (en) CONTENT DELIVERY MANAGEMENT
GB201419438D0 (en) Modifying video call data
AU201715757S (en) Phone
EP3241152A4 (en) Video triggered analyses
PL3764583T3 (pl) Schemat szeregowanej transmisji uci
GB201419441D0 (en) Modifying video call data
EP3178028A4 (en) Medication dispensing phone case
EP3114063A4 (en) Group call management
GB201914873D0 (en) Healthcare analytics management
SG11202004890WA (en) Managing content casting
GB2542592B (en) Managing interaction constraints
HUE071486T2 (hu) Nefrogén diabetes insipidus kezelése
GB201513563D0 (en) Managing interaction constraints
PT2910223T (pt) Emplastro com dispensador de medicação
GB201816681D0 (en) Coulteau å enduire
SG11201911924PA (en) Polymer compositions stabilized with organopolysulfides
GB2560036B (en) E-ear trumpet